There is no commercial support for this activity.

About The Speaker

Brad Riemann, PhD, serves as Chief Clinical Officer for Rogers Behavioral Health. Dr. Riemann is a leading expert in the assessment and treatment of obsessive-compulsive disorder (OCD) and anxiety disorders. Dr. Riemann is also the clinical director of OCD and Anxiety Adult Residential Program, one of the leading residential treatment programs for OCD and anxiety in the country. He also directs Cognitive Behavioral Therapy Services at Rogers.

Dr. Riemann supervises the training of graduate and post-graduate students from around the country for CBT in anxiety disorders and collaborates with colleges and universities on research projects investigating OCD and anxiety disorders. Dr. Riemann has authored over 100 scientific papers and eight treatment manuals on obsessive-compulsive disorder and anxiety and has spoken at national and international conventions.  Dr. Riemann received his doctorate in clinical psychology from the Chicago Medical School. He is also a clinical professor in the department of psychology at the Rosalind Franklin School of Medicine, Marquette University, and the University of Wisconsin–Milwaukee and sits on the scientific advisory board of the International OCD Foundation

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Bradley C. Riemann, PhD, reports having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months. He will not discuss any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients in this presentation. This presentation was initially planned and recorded prior to January 1, 2023; therefore, the financial disclosure statement from the speaker reflects only the preceding 12 months, as was the standard at the time. This enduring activity was last reviewed for content validity on November 17, 2023. All conflicts have been mitigated through review.

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Deepak Prabhakar, MD, Elizabeth Ryznar, MD, MSc, Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PsyD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Stacey Garnett, RN, MSN, Stephanie M. Robinson, MSN, RN, PMH-BC, NPD-BC, NE-BC , Heather Billings, RN, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.